Nifty

:

23810.85

Sensex

:

76917.85

370.05 (1.58%)
1225.07 (1.62%)

Login

Nifty
Sensex

:
:

23810.85
76917.85

370.05 (1.58%)
1225.07 (1.62%)

Lincoln Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :

62/99

BSE: 531633 | NSE: LINCOLN

Watchlist

NSE BSE

504.35

03-Nov-2026

Open
High
Low
Previous Close

519
519
501.15
512.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

20962
10716161.05
770
440

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,010.40
10.43
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

981.61
0.36%
1.25

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.42
7.28
4.95

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.65
0.46
-0.45

PAT CAGR (%)

10 Years
5 Years
3 Years

12.07
4.85
-1.97

P:E (Median)

8 Years
5 Years
3 Years

10.66
12.61
13.53

P:BV (Average)

8 Years
5 Years
3 Years

1.61
1.74
1.87

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.20
8.09
9.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 191.34 163.36 17.13% 177.28 154.07 15.06% 187.28 168.18 11.36% 166.32 146.55 13.49%
Expenses 167.66 137.94 21.55% 149.85 130.26 15.04% 162.42 141.46 14.82% 142.73 122.89 16.14%
EBITDA 23.69 25.43 -6.84% 27.43 23.81 15.20% 24.85 26.72 -7.00% 23.60 23.66 -0.25%
EBIDTM 12.38% 15.57% 15.47% 15.45% 13.27% 15.89% 14.19% 16.15%
Other Income 9.53 7.23 31.81% 24.27 15.27 58.94% -4.20 -6.88 - 15.15 8.97 68.90%
Interest 0.32 0.23 39.13% 0.26 0.21 23.81% 0.27 0.37 -27.03% 0.30 0.73 -58.90%
Depreciation 3.88 3.62 7.18% 3.88 3.48 11.49% 3.68 3.23 13.93% 3.72 3.22 15.53%
PBT 29.02 28.81 0.73% 47.55 35.39 34.36% 16.70 16.25 2.77% 34.72 28.68 21.06%
Tax 8.59 8.83 -2.72% 11.32 7.71 46.82% 5.07 4.67 8.57% 6.12 7.91 -22.63%
PAT 20.43 19.98 2.25% 36.23 27.68 30.89% 11.63 11.57 0.52% 28.60 20.77 37.70%
PATM 10.68% 12.23% 20.44% 17.96% 6.21% 6.88% 17.20% 14.17%
EPS 10.21 9.99 2.20% 18.12 13.84 30.92% 5.82 5.79 0.52% 14.30 10.38 37.76%

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 191.34 163.36 17.13% 177.28 154.07 15.06% 187.28 168.18 11.36% 166.32 146.55 13.49%
Expenses 167.66 137.94 21.55% 149.85 130.26 15.04% 162.42 141.46 14.82% 142.73 122.89 16.14%
EBITDA 23.69 25.43 -6.84% 27.43 23.81 15.20% 24.85 26.72 -7.00% 23.60 23.66 -0.25%
EBIDTM 12.38% 15.57% 15.47% 15.45% 13.27% 15.89% 14.19% 16.15%
Other Income 9.53 7.23 31.81% 24.27 15.27 58.94% -4.20 -6.88 - 15.15 8.97 68.90%
Interest 0.32 0.23 39.13% 0.26 0.21 23.81% 0.27 0.37 -27.03% 0.30 0.73 -58.90%
Depreciation 3.88 3.62 7.18% 3.88 3.48 11.49% 3.68 3.23 13.93% 3.72 3.22 15.53%
PBT 29.02 28.81 0.73% 47.55 35.39 34.36% 16.70 16.25 2.77% 34.72 28.68 21.06%
Tax 8.59 8.83 -2.72% 11.32 7.71 46.82% 5.07 4.67 8.57% 6.12 7.91 -22.63%
PAT 20.43 19.98 2.25% 36.23 27.68 30.89% 11.63 11.57 0.52% 28.60 20.77 37.70%
PATM 10.68% 12.23% 20.44% 17.96% 6.21% 6.88% 17.20% 14.17%
EPS 10.20 9.98 2.20% 18.09 13.82 30.90% 5.81 5.78 0.52% 14.28 10.37 37.70%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 722.22 671.03 623.23 580.55 510.31 472.08 422.91 376.09 353.04 324.95 304.28 Net Sales Growth 14.25% 7.67% 7.35% 13.76% 8.10% 11.63% 12.45% 6.53% 8.64% 6.79% Cost Of Goods Sold 348.07 211.90 202.66 204.07 179.43 169.70 155.05 163.02 156.55 152.12 157.91 Gross Profit 374.15 459.13 420.57 376.48 330.88 302.37 267.86 213.06 196.49 172.84 146.37 GP Margin 51.81% 68.42% 67.48% 64.85% 64.84% 64.05% 63.34% 56.65% 55.66% 53.19% 48.10% Total Expenditure 622.66 573.35 521.74 480.64 421.14 376.61 335.87 316.72 292.71 279.00 261.85 Power & Fuel Cost - 11.10 11.66 11.47 10.25 8.33 7.10 7.57 7.08 6.67 5.82 % Of Sales - 1.65% 1.87% 1.98% 2.01% 1.76% 1.68% 2.01% 2.01% 2.05% 1.91% Employee Cost - 125.19 112.45 102.90 93.16 79.72 63.20 54.90 48.40 47.51 35.05 % Of Sales - 18.66% 18.04% 17.72% 18.26% 16.89% 14.94% 14.60% 13.71% 14.62% 11.52% Manufacturing Exp. - 139.87 124.15 102.35 85.72 69.33 61.54 40.90 38.38 32.13 26.52 % Of Sales - 20.84% 19.92% 17.63% 16.80% 14.69% 14.55% 10.88% 10.87% 9.89% 8.72% General & Admin Exp. - 45.60 39.46 29.91 31.10 27.56 23.06 20.90 20.59 16.68 13.88 % Of Sales - 6.80% 6.33% 5.15% 6.09% 5.84% 5.45% 5.56% 5.83% 5.13% 4.56% Selling & Distn. Exp. - 35.43 28.25 26.71 19.20 19.46 24.34 25.88 19.37 20.65 19.85 % Of Sales - 5.28% 4.53% 4.60% 3.76% 4.12% 5.76% 6.88% 5.49% 6.35% 6.52% Miscellaneous Exp. - 4.26 3.10 3.24 2.28 2.50 1.58 3.54 2.34 3.24 19.85 % Of Sales - 0.63% 0.50% 0.56% 0.45% 0.53% 0.37% 0.94% 0.66% 1.00% 0.93% EBITDA 99.57 97.68 101.49 99.91 89.17 95.47 87.04 59.37 60.33 45.95 42.43 EBITDA Margin 13.79% 14.56% 16.28% 17.21% 17.47% 20.22% 20.58% 15.79% 17.09% 14.14% 13.94% Other Income 44.75 33.45 22.48 34.42 22.48 10.00 5.74 12.13 6.58 5.80 2.57 Interest 1.15 1.01 1.88 1.46 2.03 1.45 1.55 1.98 3.84 4.26 5.41 Depreciation 15.16 14.50 12.90 10.62 9.17 8.09 7.56 5.47 4.92 4.40 3.85 PBT 127.99 115.63 109.19 122.24 100.46 95.93 83.67 64.05 58.14 43.10 35.74 Tax 31.10 27.73 26.84 28.94 27.56 26.57 21.42 14.48 11.51 10.34 8.34 Tax Rate 24.30% 23.98% 24.58% 23.67% 27.43% 27.70% 25.60% 22.61% 19.80% 23.99% 23.34% PAT 96.89 87.89 82.35 93.30 72.90 69.35 62.25 49.56 46.64 32.76 27.40 PAT before Minority Interest 96.89 87.89 82.35 93.30 72.90 69.35 62.25 49.56 46.64 32.76 27.40 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.42% 13.10% 13.21% 16.07% 14.29% 14.69% 14.72% 13.18% 13.21% 10.08% 9.00% PAT Growth 21.11% 6.73% -11.74% 27.98% 5.12% 11.41% 25.61% 6.26% 42.37% 19.56% EPS 48.45 43.95 41.18 46.65 36.45 34.68 31.13 24.78 23.32 16.38 13.70

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 722.22 671.03 623.23 580.55 510.31 472.12 424.19 386.49 366.15 360.61 360.26 Net Sales Growth 14.25% 7.67% 7.35% 13.76% 8.09% 11.30% 9.75% 5.56% 1.54% 0.10% Cost Of Goods Sold 348.07 211.90 202.66 204.07 179.43 169.71 155.86 138.15 135.66 156.44 202.90 Gross Profit 374.15 459.13 420.57 376.48 330.88 302.41 268.32 248.34 230.49 204.18 157.35 GP Margin 51.81% 68.42% 67.48% 64.85% 64.84% 64.05% 63.25% 64.26% 62.95% 56.62% 43.68% Total Expenditure 622.66 573.35 521.74 480.64 421.11 376.64 337.01 320.95 298.91 308.30 313.52 Power & Fuel Cost - 11.10 11.66 11.47 10.25 8.33 7.10 8.18 7.21 6.82 5.92 % Of Sales - 1.65% 1.87% 1.98% 2.01% 1.76% 1.67% 2.12% 1.97% 1.89% 1.64% Employee Cost - 125.19 112.45 102.90 93.16 79.72 63.26 58.65 51.90 51.15 37.59 % Of Sales - 18.66% 18.04% 17.72% 18.26% 16.89% 14.91% 15.18% 14.17% 14.18% 10.43% Manufacturing Exp. - 139.87 124.15 102.35 85.72 69.33 61.54 64.05 60.71 51.73 29.44 % Of Sales - 20.84% 19.92% 17.63% 16.80% 14.68% 14.51% 16.57% 16.58% 14.35% 8.17% General & Admin Exp. - 45.60 39.46 29.91 31.06 27.56 23.06 21.30 20.98 17.50 14.78 % Of Sales - 6.80% 6.33% 5.15% 6.09% 5.84% 5.44% 5.51% 5.73% 4.85% 4.10% Selling & Distn. Exp. - 35.43 28.25 26.71 19.20 19.49 24.54 26.79 20.02 21.24 19.91 % Of Sales - 5.28% 4.53% 4.60% 3.76% 4.13% 5.79% 6.93% 5.47% 5.89% 5.53% Miscellaneous Exp. - 4.26 3.10 3.23 2.28 2.51 1.64 3.83 2.43 3.44 19.91 % Of Sales - 0.63% 0.50% 0.56% 0.45% 0.53% 0.39% 0.99% 0.66% 0.95% 0.82% EBITDA 99.57 97.68 101.49 99.91 89.20 95.48 87.18 65.54 67.24 52.31 46.74 EBITDA Margin 13.79% 14.56% 16.28% 17.21% 17.48% 20.22% 20.55% 16.96% 18.36% 14.51% 12.97% Other Income 44.75 33.45 22.48 34.42 22.47 10.00 5.66 11.04 5.63 5.45 2.78 Interest 1.15 1.01 1.88 1.46 2.03 1.45 1.56 2.02 4.00 5.41 6.66 Depreciation 15.16 14.50 12.90 10.62 9.17 8.09 7.56 7.33 6.68 6.11 5.51 PBT 127.99 115.63 109.19 122.24 100.48 95.94 83.72 67.23 62.19 46.25 37.33 Tax 31.10 27.73 26.84 28.94 27.58 26.58 21.47 15.77 13.46 11.60 9.20 Tax Rate 24.30% 23.98% 24.58% 23.67% 27.45% 27.70% 25.65% 23.46% 21.64% 25.08% 24.65% PAT 96.89 87.89 82.35 93.30 72.90 69.36 62.25 51.44 48.71 34.62 28.12 PAT before Minority Interest 96.89 87.89 82.35 93.30 72.90 69.36 62.25 51.47 48.74 34.65 28.13 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.03 -0.03 -0.01 PAT Margin 13.42% 13.10% 13.21% 16.07% 14.29% 14.69% 14.68% 13.31% 13.30% 9.60% 7.81% PAT Growth 21.11% 6.73% -11.74% 27.98% 5.10% 11.42% 21.01% 5.60% 40.70% 23.12% EPS 48.45 43.95 41.18 46.65 36.45 34.68 31.13 25.72 24.36 17.31 14.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 757.63 671.67 592.84 502.47 432.88 366.39 304.49 262.60 219.54 189.58 Share Capital 20.03 20.03 20.03 20.03 20.03 20.03 20.00 20.00 20.00 20.00 Total Reserves 737.60 651.64 572.81 482.44 412.85 346.36 284.49 242.60 199.54 169.58 Non-Current Liabilities 21.73 19.12 15.18 38.02 41.74 40.87 37.99 24.91 22.89 25.79 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.14 0.52 1.69 6.13 7.11 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.76 0.73 0.10 25.36 30.75 30.75 30.75 16.46 7.19 9.98 Current Liabilities 136.62 130.95 117.27 95.85 110.46 93.45 69.44 90.02 98.80 83.56 Trade Payables 84.72 84.81 72.30 50.73 71.43 56.56 42.00 35.71 35.04 24.94 Other Current Liabilities 13.99 14.78 15.18 14.51 9.84 13.43 8.47 9.93 5.91 6.76 Short Term Borrowings 4.42 0.00 1.07 2.00 2.04 0.00 3.83 30.09 48.55 44.13 Short Term Provisions 33.48 31.36 28.73 28.61 27.15 23.46 15.14 14.29 9.30 7.73 Total Liabilities 915.98 821.74 725.29 636.34 585.08 500.71 411.92 377.53 341.23 298.93 Net Block 190.95 181.97 179.33 150.53 131.88 110.64 91.03 88.45 82.95 68.07 Gross Block 274.24 251.98 236.65 197.47 171.07 141.90 108.01 100.52 90.65 71.86 Accumulated Depreciation 83.29 70.01 57.32 46.95 39.19 31.26 16.98 12.07 7.70 3.79 Non Current Assets 307.40 297.12 262.56 245.47 212.30 174.40 182.58 168.72 142.95 137.82 Capital Work in Progress 5.23 4.47 3.48 6.71 16.05 1.69 0.04 1.94 0.29 6.63 Non Current Investment 0.05 0.05 0.05 0.05 0.05 0.05 25.79 27.74 27.74 25.74 Long Term Loans & Adv. 111.05 110.63 79.70 88.18 62.57 61.57 65.69 50.27 31.63 37.02 Other Non Current Assets 0.12 0.00 0.00 0.00 1.75 0.45 0.03 0.33 0.34 0.36 Current Assets 608.58 524.62 462.72 390.87 372.78 326.31 229.35 208.81 198.29 161.10 Current Investments 208.54 173.72 138.92 91.33 96.81 80.66 34.22 18.07 10.97 10.25 Inventories 80.11 78.68 77.17 70.03 72.74 46.61 37.54 29.47 36.49 31.87 Sundry Debtors 160.58 165.53 160.90 135.47 115.04 112.12 91.00 113.00 96.02 79.23 Cash & Bank 32.22 21.99 13.39 33.85 18.43 13.43 11.21 7.43 8.35 5.39 Other Current Assets 127.13 3.86 2.91 3.32 69.76 73.49 55.38 40.84 46.46 34.37 Short Term Loans & Adv. 124.10 80.85 69.44 56.88 67.16 70.88 53.34 38.75 44.37 33.01 Net Current Assets 471.96 393.67 345.45 295.02 262.31 232.86 159.91 118.79 99.48 77.55 Total Assets 915.98 821.74 725.28 636.34 585.08 500.71 411.93 377.53 341.24 298.92

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 757.63 671.67 592.84 502.47 432.88 366.39 313.09 269.34 224.22 192.38 Share Capital 20.03 20.03 20.03 20.03 20.03 20.03 20.00 20.00 20.00 20.00 Total Reserves 737.60 651.64 572.81 482.44 412.85 346.36 293.09 249.34 204.22 172.38 Non-Current Liabilities 21.73 19.12 15.18 38.02 10.99 26.10 42.85 28.43 24.94 31.75 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.14 0.85 1.69 6.93 12.38 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.76 0.73 0.10 25.36 0.00 15.98 32.51 17.49 7.19 9.98 Current Liabilities 136.76 131.09 117.41 96.01 110.71 94.78 80.32 100.37 113.48 99.42 Trade Payables 84.86 84.95 72.44 50.87 71.67 57.07 51.24 44.01 43.42 32.46 Other Current Liabilities 13.99 14.78 15.18 14.51 9.84 13.43 9.13 11.11 11.11 12.77 Short Term Borrowings 4.42 0.00 1.07 2.00 2.04 0.00 3.83 30.09 48.55 45.04 Short Term Provisions 33.48 31.36 28.73 28.64 27.16 24.28 16.11 15.16 10.41 9.15 Total Liabilities 916.12 821.88 725.43 636.50 554.58 487.27 436.64 398.50 362.97 323.85 Net Block 190.95 181.97 179.33 150.53 131.88 110.64 122.72 120.91 116.58 102.71 Gross Block 274.24 251.98 236.65 197.47 171.07 141.90 146.70 138.11 127.65 108.16 Accumulated Depreciation 83.29 70.01 57.32 46.95 39.19 31.26 23.98 17.21 11.08 5.45 Non Current Assets 307.35 297.07 262.51 245.42 181.51 159.59 173.91 159.43 136.08 134.27 Capital Work in Progress 5.23 4.47 3.48 6.71 16.05 1.69 0.04 2.10 0.29 6.63 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.09 0.09 0.09 Long Term Loans & Adv. 111.05 110.63 79.70 88.18 31.83 46.81 51.02 36.01 18.79 24.48 Other Non Current Assets 0.12 0.00 0.00 0.00 1.75 0.45 0.03 0.33 0.34 0.36 Current Assets 608.77 524.81 462.91 391.08 373.07 327.69 262.73 239.08 226.88 189.58 Current Investments 208.54 173.72 138.92 91.33 96.81 80.66 34.22 18.07 10.97 10.25 Inventories 80.11 78.68 77.17 70.03 72.74 46.61 47.40 36.23 45.41 37.31 Sundry Debtors 161.45 166.40 161.77 136.33 115.94 113.35 101.34 122.47 109.44 90.67 Cash & Bank 32.66 22.43 13.83 34.32 18.80 13.84 14.58 7.58 14.59 11.68 Other Current Assets 126.03 2.64 1.69 2.10 68.78 73.22 65.20 54.74 46.47 39.68 Short Term Loans & Adv. 124.21 80.95 69.54 56.98 67.59 71.79 64.09 53.64 45.18 39.02 Net Current Assets 472.01 393.72 345.50 295.07 262.36 232.91 182.41 138.71 113.40 90.16 Total Assets 916.12 821.88 725.42 636.50 554.58 487.28 436.64 398.51 362.96 323.85

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 106.36 93.02 63.24 39.16 76.18 69.39 70.71 51.06 21.33 17.80 PBT 115.63 109.19 122.24 100.46 95.93 83.67 64.05 58.14 43.10 35.74 Adjustment 6.32 0.96 -16.76 -0.29 1.49 4.75 5.38 6.53 7.95 7.85 Changes in Working Capital 9.56 9.17 -16.12 -31.40 2.40 0.42 15.27 3.01 -21.03 -16.93 Cash after chg. in Working capital 131.50 119.32 89.37 68.76 99.82 88.84 84.69 67.69 30.02 26.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -25.14 -26.31 -26.13 -29.61 -23.64 -19.45 -13.98 -16.63 -8.69 -8.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -98.40 -78.95 -57.34 -36.64 -78.08 -64.39 -28.99 -22.32 -13.64 -25.90 Net Fixed Assets -23.02 -16.32 -35.95 -17.06 -43.53 -35.54 -5.59 -11.52 -12.45 4.05 Net Investments -34.82 -34.80 -47.59 5.48 -16.15 -20.70 -14.20 -7.10 -2.72 -16.01 Others -40.56 -27.83 26.20 -25.06 -18.40 -8.15 -9.20 -3.70 1.53 -13.94 Cash from Financing Activity 0.16 -6.40 -5.18 -4.50 -2.56 -5.74 -38.10 -29.88 -4.17 8.05 Net Cash Inflow / Outflow 8.12 7.67 0.73 -1.99 -4.46 -0.74 3.61 -1.14 3.51 -0.05 Opening Cash & Equivalents 12.97 5.31 4.58 6.57 11.03 11.77 5.31 6.45 2.93 2.98 Closing Cash & Equivalent 21.09 12.97 5.31 4.58 6.57 11.03 8.92 5.31 6.45 2.93

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 106.36 93.02 63.22 39.26 76.13 69.27 75.42 52.84 26.63 25.04 PBT 115.63 109.19 122.24 100.48 95.94 83.72 67.23 62.19 46.25 37.33 Adjustment 6.32 0.96 -16.76 -0.23 1.48 4.84 8.66 9.30 11.64 10.70 Changes in Working Capital 9.56 9.17 -16.12 -31.37 2.40 0.20 14.33 -1.12 -22.00 -13.24 Cash after chg. in Working capital 131.50 119.32 89.37 68.87 99.83 88.76 90.22 70.38 35.88 34.79 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -25.14 -26.31 -26.15 -29.61 -23.70 -19.49 -14.81 -17.53 -9.25 -9.75 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -98.41 -78.95 -57.34 -36.64 -78.08 -64.23 -30.88 -18.19 -11.77 -25.48 Net Fixed Assets -23.02 -16.32 -35.95 -17.06 -43.53 -35.54 -5.59 -11.52 -12.45 4.05 Net Investments -34.82 -34.80 -47.59 5.48 -16.15 -20.70 -14.20 -7.10 -2.72 -16.01 Others -40.57 -27.83 26.20 -25.06 -18.40 -7.99 -11.09 0.43 3.40 -13.52 Cash from Financing Activity 0.16 -6.40 -5.18 -4.50 -2.56 -5.75 -37.76 -35.77 -11.41 0.30 Net Cash Inflow / Outflow 8.11 7.67 0.70 -1.88 -4.50 -0.70 6.77 -1.11 3.45 -0.14 Opening Cash & Equivalents 13.41 5.75 5.05 6.93 11.44 12.14 5.46 6.57 3.12 3.26 Closing Cash & Equivalent 21.53 13.41 5.75 5.05 6.93 11.44 12.23 5.46 6.57 3.12

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 378.25 335.34 295.98 250.86 216.12 182.92 152.25 131.30 109.77 94.79 ROA 10.12% 10.65% 13.70% 11.94% 12.77% 13.64% 12.56% 12.98% 10.23% 10.13% ROE 12.30% 13.02% 17.04% 15.59% 17.35% 18.56% 17.48% 19.35% 16.01% 17.09% ROCE 16.27% 17.55% 22.53% 21.82% 24.29% 25.21% 21.81% 21.68% 18.28% 18.63% Fixed Asset Turnover 2.66 2.67 2.80 2.90 3.17 3.50 3.73 3.81 4.01 4.06 Receivable days 84.89 91.27 89.11 85.49 83.49 84.77 95.66 104.80 98.26 91.46 Inventory Days 41.33 43.57 44.26 48.72 43.87 35.12 31.42 33.07 38.33 33.50 Payable days 146.01 141.48 110.02 124.24 137.63 116.01 47.29 47.41 42.28 32.45 Cash Conversion Cycle -19.79 -6.64 23.34 9.97 -10.27 3.89 79.80 90.46 94.30 92.51 Total Debt/Equity 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.13 0.26 0.28 Interest Cover 115.15 59.00 84.58 50.51 67.12 54.90 33.29 16.13 11.11 7.60

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 378.25 335.34 295.98 250.86 216.12 182.92 156.54 134.67 112.11 96.19 ROA 10.11% 10.64% 13.70% 12.24% 13.31% 13.48% 12.33% 12.80% 10.09% 9.40% ROE 12.30% 13.02% 17.04% 15.59% 17.35% 18.32% 17.67% 19.75% 16.63% 17.29% ROCE 16.27% 17.55% 22.53% 21.82% 24.29% 24.90% 22.30% 22.50% 19.05% 18.51% Fixed Asset Turnover 2.66 2.67 2.80 2.90 3.17 3.04 2.81 2.84 3.07 3.19 Receivable days 85.34 91.75 89.63 86.09 84.27 89.34 102.22 112.23 100.99 85.52 Inventory Days 41.33 43.57 44.26 48.72 43.86 39.12 38.19 39.51 41.74 32.36 Payable days 146.25 141.73 110.27 124.63 138.44 126.82 56.60 57.26 47.62 37.21 Cash Conversion Cycle -19.58 -6.41 23.61 10.19 -10.30 1.64 83.82 94.48 95.11 80.67 Total Debt/Equity 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.12 0.27 0.34 Interest Cover 115.14 58.99 84.45 50.49 67.11 54.61 34.32 16.56 9.55 6.60

Top Investors:

rimo capital fund lp

dheeraj kumar lohia

Annual Reports:

News Update:

Lincoln Pharma - Quarterly Results
30th Oct 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback